|
|
|
|
|
7:55-5:30
|
PW1 Pre-Conference Critical Care Nephrology Symposium
|
|
|
|
|
|
|
|
Innovations in Acute Kidney Injury and Extracorporeal Organ Support
|
|
|
|
|
|
|
Critical Care Nephrology Symposium
PLENARY 1 The Discovery Pipeline: Molecules, Mechanisms and Targets
|
|
|
Co-chair: Prabhleen Singh, MD
Co-chair: Alex Zarbock, MD
|
|
|
|
|
|
|
|
|
|
7:55-8:00
|
Opening Remarks
|
|
|
|
Ravindra L. Mehta, MBBS, MD, DM, FACP
|
|
|
|
|
|
|
|
|
|
8:00-8:20
|
Developing a Precision Approach to Sepsis and Sepsis-Associated AKI
|
|
|
|
Robert Star, MD
|
|
|
|
|
|
|
|
|
|
8:20-8:40
|
Molecular Endotypes of Sepsis and AKI
|
|
|
|
John A. Kellum, MD Slides
|
|
|
|
|
|
|
|
|
|
8:40-9:00
|
Tubular Transporters: Targets for AKI?
|
|
|
|
Volker Vallon, MD
|
|
|
|
|
|
|
|
|
|
9:00-9:20
|
Sex as a Biological Variable for AKI
|
|
|
|
Danielle Soranno, MD
|
|
|
|
|
|
|
|
|
|
9:20-9:40
|
Role of the CD40-Ligand Pathway in Tissue Injury of Native and Transplanted Kidney
|
|
|
|
Vincenzo Cantaluppi, MD
|
|
|
|
|
|
|
|
|
|
9:40-10:00
|
Discussion
|
|
|
|
|
|
|
|
|
|
|
|
|
|
10:00-10:15
|
Coffee Break
|
|
|
|
|
|
|
|
|
|
|
|
|
|
10:15-10:35
|
Critical Care Nephrology Symposium
PLENARY 2 Bench to Bedside: Translating Discoveries to Clinical Care
|
|
|
Co-chair: Vincenzo Cantaluppi, MD
Co-chair: Danielle Soranno, MD
|
|
|
|
|
|
|
|
|
|
10:15-10:35
|
The Biphasic Effect of Angiotensin II on AKI
|
|
|
|
Luis Juncos, MD
|
|
|
|
|
|
|
|
|
|
10:35-10:55
|
Mitophagy as a Therapeutic Target in AKI
|
|
|
|
John Prowle, MA, MD, FFICM, FRCP
|
|
|
|
|
|
|
|
|
|
10:55-11:15
|
Complementary Role of Kidney Biomarkers and Transcriptomic Endotyping in Sepsis Associated AKI
|
|
|
|
Christian Nusshag, MD
|
|
|
|
|
|
|
|
|
|
11:15-11:35
|
Kidney Microphysiological Models for Nephrotoxicity Assessment
|
|
|
|
SeJoong Kim, Professor
|
|
|
|
|
|
|
|
|
|
11:35-11:55
|
Human Kidney Precision Medicine Project (KPMP)
|
|
|
|
Jonathan Himmelfarb, Professor of Medicin
|
|
|
|
|
|
|
|
|
|
11:55-12:15
|
Discussion
|
|
|
|
|
|
|
|
|
|
|
|
|
|
12:15-1:15
|
Lunch Hosted by Conference for Critical Care Symposium Participants
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1:15-1:35
|
Critical Care Nephrology Symposium
PLENARY 3 Emerging Strategies for AKI Studies
|
|
|
Co-chair: Matthieu LeGrand, MD, PhD
Co-chair: Kathleen Liu, MD, PhD, MAS
|
|
|
|
|
|
|
|
|
|
1:15-1:35
|
Dynamic Kidney Function Monitoring
|
|
|
|
Stuart L. Goldstein, MD
|
|
|
|
|
|
|
|
|
|
1:35-1:55
|
Theranostics: Biomarker Guided Interventions
|
|
|
|
Alex Zarbock, MD
|
|
|
|
|
|
|
|
|
|
1:55-2:15
|
Predictive Analytics and Simulations for Trial Design and Implementation
|
|
|
|
Andrew D. Shaw, MB, FRCA, FRCPC
|
|
|
|
|
|
|
|
|
|
2:15-2:35
|
Platform Trials for AKI: What Would it Take?
|
|
|
|
Derek Angus, Dr.
|
|
|
|
|
|
|
|
|
|
2:35-2:55
|
Surrogate Endpoints for Regulatory Approval: What?s Needed?
|
|
|
|
Bhupinder Singh, MD
|
|
|
|
|
|
|
|
|
|
2:55-3:15
|
Discussion
|
|
|
|
|
|
|
|
|
|
|
|
|
|
3:15-3:30
|
Coffee Break
|
|
|
|
|
|
|
|
|
|
|
|
|
|
3:30-3:50
|
Critical Care Nephrology Symposium
PLENARY 4 Evolving Paradigms: Lessons from Ongoing Trials
|
|
|
Co-chair: Marlies Ostermann, PhD
Co-chair: Ron Wald, MD
|
|
|
|
|
|
|
|
|
|
3:30-3:50
|
One Size Does Not Fit All: The Role of Phenotyping
|
|
|
|
Jean-Louis Vincent, MD PhD
|
|
|
|
|
|
|
|
|
|
3:50-4:10
|
Reappraising MAKE Performance in AKI Trials: What do We Know?
|
|
|
|
Ravindra L. Mehta, MBBS, MD, DM, FACP
|
|
|
|
|
|
|
|
|
|
4:10-4:30
|
Heterogeneity of Treatment Effect
|
|
|
|
Derek Angus, Dr.
|
|
|
|
|
|
|
|
|
|
4:30-4:50
|
Overcoming Barriers in the Design and Implementation of Clinical Trials for AKI
|
|
|
|
Matthieu LeGrand, MD, PhD
|
|
|
|
|
|
|
|
|
|
4:50-5:10
|
Implementing Device Trials: What does it Require?
|
|
|
|
John A. Kellum, MD Slides
|
|
|
|
|
|
|
|
|
|
5:10-5:30
|
Discussion
|
|
|
|
|
|
|
|
|
|
|
|
|
|
5:30pm
|
Critical Care Nephrology Symposium Adjourns
|
|
|
|
|
|
|
|
|
|
|
|
|
|
\
|
POCUS Workshop
|
|
|
|
|
|
|
|
|
|
|
|
|
8:00-4:00
|
PW3 PRE-CONFERENCE POCUS WORKSHOP
Point of Care Ultrasound (POCUS): Science and Practice
|
|
|
|
William Beaubien-Souligny, Dr
Jean Deschamps, Dr
Kianoush Kashani, MD, MS
Vandana Niyyar, Dr.
Andrew D. Shaw, MB, FRCA, FRCPC
Ron Wald, MD
|
|
|
|
|
|
|
|
|
|
5:30-7:30pm
|
Reception and Poster Review
For All Conference Attendees
|
|
|
|
Dana Fuhrman, DO, MS
Stuart L. Goldstein, MD
Luis Juncos, MD
SeJoong Kim, Professor
Neesh Pannu, MD
|
|
|
|
ORAL POSTER SESSIONS:
CLINICAL RESEARCH IN AKI - I
Fuhrman (Moderator)
TRANSLATIONAL RESEARCH
Juncos and Kim (Moderators)
EPI AND OUTCOMES - I
Pannu and Goldstein (Moderators)
|
|
|
|
|
|
|
|
|
|
|
|
Wednesday Morning, March 13
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
7:00am
|
Conference Registration Open
|
|
|
|
|
|
|
|
|
|
|
|
|
|
7:00-8:00
|
Meet the Experts (elective event)
|
|
|
|
|
|
|
|
|
|
|
|
|
7:00-8:00
|
ME1 MEET THE EXPERT
How do I Manage the Patient with Septic AKI
|
|
|
|
Derek Angus, Dr.
Jean-Louis Vincent, MD PhD
|
|
|
|
|
|
|
|
|
|
7:00-8:00
|
ME2 MEET THE EXPERT
How do I Dose Volume During CRRT?
|
|
|
|
Claudio Ronco, MD
Ashita Tolwani, MD
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
Morning Symposia
|
|
|
|
|
|
|
|
|
|
|
|
|
7:00-8:00
|
Morning Symposium A - Plasma Exchange in Critically Ill Patients: Who, When and How
|
|
|
|
Ian Baldwin, RN, PhD, FACCCN
Akash Deep, Professor
Dana Fuhrman, DO, MS Slides
Vedran Premuzic, M.D., Ph.D.
|
|
|
|
CME Available
Plasma exchange (PE) is increasingly utilized in the ICU with CRRT and other extracorporeal techniques. This symposium will describe the best approaches for applying PE in critically ill patients and explore merging opportunities for managing patients with hybrid therapies.
Akash Deep and Ian Baldwin (Moderator)
Vedran Premuzic and Dana Fuhrman (Discussants) Slides
|
|
|
|
|
|
7:00-8:00
|
Morning Symposium B - Deresuscitation in the ICU: How to use Diuretics, Ultrafiltration and Dialysis
|
|
|
|
Katja Gist, DO, MSc
Amir Kazory, MD, FASN, FACC Slides
Matthieu LeGrand, MD, PhD
Patrick T. Murray, MD
Raghavan Murugan, MD, MS, FRCP
|
|
|
|
CME Available
There is increasing evidence that different patient respond differently to fluids and vasopressor management for shock. This symposium will discuss how best we may identify phenotypes to personalize fluid type (colloids and crystalloids and blood products) and volume and vasopressor management in shock patients to improve outcomes.
Kat Gist and Matthew Legrand (Moderators)
Patrick Murray, Amir Kazory and Raghavan Murugan (Discussants)
Diuretic Strategies in Patients Who are Resistant to Loop Diuretics - Patrick Murray
Ultrafiltration and Diuretic Therapy in Acute Heart Failure - Amir Kazory Slides
Fluid Removal with CRRT: How Much and How Fast? - Raghavan Murugan
|
|
|
|
|
|
7:00-8:00
|
S1. Optional Industry Breakfast Session (Non-CME)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
SESSION I: PATIENT CHARACTERISTICS
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
8:20-8:30
|
Plenary 1 MINI-SYMPOSIA
Organ Dysfunction in the Critically Ill Patient: Emerging Concepts
|
|
|
Co-chair: Michael Joannidis, Professor, MD
Co-chair: Neesh Pannu, MD
|
|
|
|
|
|
|
|
|
|
8:20-8:30
|
Opening Remarks
|
|
|
|
Ravindra L. Mehta, MBBS, MD, DM, FACP
|
|
|
|
|
|
|
|
|
|
8:30-8:45
|
Hidden in Plain Sight; Chloride in Acute Heart Failure
|
|
|
|
Amir Kazory, MD, FASN, FACC Slides
|
|
|
|
|
|
|
|
|
|
8:45-9:00
|
What's New in Organ Crosstalk
|
|
|
|
Kathleen Liu, MD, PhD, MAS
|
|
|
|
|
|
|
|
|
|
9:00-9:15
|
Sepsis in 2024: What's Next?
|
|
|
|
Derek Angus, Dr.
|
|
|
|
|
|
|
|
|
|
9:15-9:30
|
Trajectories of Critical Illness - Defining Endotypes from Routine Data
|
|
|
|
John Prowle, MA, MD, FFICM, FRCP
|
|
|
|
|
|
|
|
|
|
9:30-9:45
|
Early Multi-modal Vasopressors in Critical Care - Is That a Thing?
|
|
|
|
Ashish Khanna, MD MS FCCP FCCM FASA
|
|
|
|
|
|
|
|
|
|
9:45-10:00
|
The Forgotten (Right) Ventricle in Critical Care Medicine
|
|
|
|
Andrew D. Shaw, MB, FRCA, FRCPC
|
|
|
|
|
|
|
|
|
|
10:00-10:30
|
SPECIAL LECTURE
Greening Critical Care: Can We Do It?
|
|
|
|
Derek Angus, Dr.
Marlies Ostermann, PhD
Claudio Ronco, MD
Jean-Louis Vincent, MD PhD
|
|
|
|
Yes: Jean-Louis Vincent
Maybe: Marlies Ostermann
No: Derek Angus
Moderator: Claudio Ronco
|
|
|
|
|
|
10:30-11:00
|
Coffee Break and Faculty Picture
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
STANDARD WORKSHOPS
|
|
|
|
|
|
|
|
Open to all participants and applicable to physicians, nurses and allied personnel.
Workshop Codes: C= Core workshop, I = Intermediate, A = Advanced, N= Nurses, AP = of interest to nurses and allied personnel
Workshops presented in a series are marked with a "1" for a primary workshop discussion in this area and "2" for a more complex or advanced discussion in this area. Please note that the series workshops 1 and 2 can be either taken subsequently (following each other) or they can each be taken independently (e.g. workshop 1 can be taken without taking workshop 2 and vice versa).
|
|
|
|
|
|
11:00-12:30
|
Standard Workshop Group 1
|
|
|
|
|
|
|
|
|
|
|
|
|
11:00-12:30
|
A01 Enhancing Communication in the Workplace: Conversations in Clinical Encounters
|
|
|
|
John-Michael Maury
Gita Mehta, MD Slides
Marlies Ostermann, PhD
|
|
|
|
This experiential workshop is designed to support patient care by promoting curiosity, listening and perspective taking skills and will include ways to achieve competence in responding mindfully to stressful and demanding situations in patient encounters. Along with brief interactive didactics, we will use medical improv, reflective and experiential exercises to enhance skills for patient interactions.
|
|
|
|
|
|
11:00-12:30
|
B02 Citrate Anticoagulation for CRRT: How to Use it?
|
|
|
|
Michael Joannidis, Professor, MD
Zaccaria Ricci, MD
Ashita Tolwani, MD
|
|
|
|
Regional citrate anticoagulation (RCA) is increasingly utilized for CRRT. Advances in technology have enabled automated citrate anticoagulation. However, concerns remain about its ease of use and application in patients with liver failure and reduced tissue perfusion. This workshop will discuss the best approaches for utilizing RCA for CRRT.
|
|
|
|
|
|
11:00-12:30
|
C03 Focus on POCUS: Assessment of Fluid Responsiveness, Hemodynamic Monitoring and Targets
|
|
|
|
William Beaubien-Souligny, Dr
Jean Deschamps, Dr
Dana Fuhrman, DO, MS Slides
|
|
|
|
Determining which patient needs fluids, what type, when and how much will be addressed in this workshop which will cover the principles and strategies for volume assessment with point of care ultrasound and hemodynamic monitoring in critically ill patients.
|
|
|
|
|
|
11:00-12:30
|
D04 Managing Patients with Combined Kidney and Liver Failure
|
|
|
|
Akash Deep, Professor
Luis Juncos, MD
Mitra Nadim, MD, FASN
|
|
|
|
Patients with combined liver and kidney failure are difficult to manage. This workshop will discuss the pathophysiology and illustrate best approaches for differential diagnosis and management of these patients.
|
|
|
|
|
|
12:30-2:00
|
Lunch Symposia Hosted by Conference (RSVP Required)
Selection made during registration - Non-CME
|
|
|
|
|
|
|
|
|
|
|
|
|
|
12:30-2:00
|
Lunch Symposia
|
|
|
|
|
|
|
|
|
|
|
|
|
12:30-2:00
|
W1 Lost in Translation: Communication issues in Critical Care
|
|
|
|
Sean Bagshaw, MD, MSc
Rajit Basu, MD MS FCCM
Jorge Cerda, MD, MS, FACP, FASN,
Dana Fuhrman, DO, MS
Gita Mehta, MD
|
|
|
|
Despite our best intentions, conversations with caregivers and patients and their surrogates often don?t go as planned. Strategies for effective communication need to recognize complexities to how families will perceive their interactions with the healthcare team. This symposium will review the evidence for approaches to improve communication when patients are often incapacitated, emotions run high and our unconscious bias is in play. Non-CME
Moderators: Jorge Cerda and Raj Basu
Presenters:
Navigating Conflict or Mis-alignment of Expectations - Sean Bagshaw
Difficult Decisions with Family and Caregivers - Dana Fuhrman
The Case for Compassion - Gita Mehta
|
|
|
|
|
|
12:30-2:00
|
W2 Persistent Renal Vulnerability after AKI Recovery: Do Biomarkers Have a Role?
|
|
|
|
Jay Koyner, MD
Patrick T. Murray, MD
Christian Nusshag, MD
John Prowle, MA, MD, FFICM, FRCP
Michael Zappitelli, MD, MSc
|
|
|
|
Current paradigms of kidney functional recovery from AKI are based on alterations in serum creatinine and urine output and are often dissociated with the underlying structural damage that may persist and increase the subclinical predisposition to new renal damage and subsequent progression to CKD. The availability of several biomarkers of kidney function and damage provides new approaches to evaluate patients post AKI and target appropriate interventions. This symposium will discuss the role of biomarkers post AKI to enhance patient management. Non-CME
Moderators: Patrick Murray and Michael Zappitelli
Presenters:
Assessment of Kidney Function During and After AKI - John Prowle
Marrying the FST and Damage Markers to Assess Subclinical AKD - Jay Koyner
Role of Penenkephalin in Assessing Recovery from AKI and AKI-D - Christian Nusshag
|
|
|
|
|
|
12:30-2:00
|
I1 Optional Industry Lunch Session (Non-CME)
|
|
|
|
|
|
|
|
|
|
12:30-2:00
|
I2 Optional Industry Lunch Session (Non-CME)
|
|
|
|
|
|
|
|
|
|
|
|
Wednesday, Afternoon, March 13
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2:00-3:30
|
Standard Workshop Group 2
|
|
|
|
|
|
|
|
|
|
|
|
|
2:00-3:30
|
A05 Enhancing Communication in the Workplace: Addressing Conflict and Uncertainty
|
|
|
|
Rajit Basu, MD MS FCCM
Dana Fuhrman, DO, MS
Kianoush Kashani, MD, MS
Gita Mehta, MD
|
|
|
|
This workshop will share evidence-based communication tools useful in situations of conflict and decisional uncertainty. We will use clinical scenarios with role-plays to highlight challenges in decisional conversations with patients of diverse ages, cultures, and socio-economic status, and especially on situations of conflict with patients and families regarding treatment.
|
|
|
|
|
|
2:00-3:30
|
B06 Precision Solute Control and Dynamic Dosing with CRRT?
|
|
|
|
Rolando Claure-Del Granado, MD, FASN, FISN Slides
Manish Kaushik, MD
John Prowle, MA, MD, FFICM, FRCP
|
|
|
|
CRRT techniques have evolved with availability of new technology to customize dialysis delivery. This interactive case based workshop will discuss how to apply the technology for dose adjustments, monitoring for adequacy, modality selection and transitions in CRRT.
|
|
|
|
|
|
2:00-3:30
|
C07 Starting, Transitioning and Stopping RRT for AKI: Science and Art
|
|
|
|
Sean Bagshaw, MD, MSc
Nuttha Lumlertgul, MD, PhD
Ravindra L. Mehta, MBBS, MD, DM, FACP
|
|
|
|
One of the most vexing issues for clinicians is determining when to initiate RRT in critically ill patients, when and how to transition modalities and when it can be stopped. This workshop will use case studies to explore various approaches and establish the principles for clinical decisions for renal support.
|
|
|
|
|
|
2:00-3:30
|
D08 Managing patients with Sepsis: Modifying the Course with (ECOS)
|
|
|
|
Vincenzo Cantaluppi, MD
Peter Pickkers, MD, PhD
Thiago Reis, MD
|
|
|
|
Septic patients often require ECOS to allow time for recovery. This workshop covers the rationale and strategies for the practical application of extracorporeal support techniques for sepsis. Case studies will be utilized to delineate different options.
|
|
|
|
|
|
3:30-4:00
|
Coffee Break
|
|
|
|
|
|
|
|
|
|
|
|
|
|
4:00-4:15
|
Plenary 2 MINI-SYMPOSIA
Acute Kidney Injury (AKI): Pathophysiology
|
|
|
Co-chair: Samira Bell, MBChB, FRCP, MD
Co-chair: Luis Juncos, MD
|
|
|
|
|
|
|
|
|
|
4:00-4:15
|
AKI in the Neurocritical Unit
|
|
|
|
Zaccaria Ricci, MD
|
|
|
|
|
|
|
|
|
|
4:15-4:30
|
AKI After Burn injury
|
|
|
|
Matthieu LeGrand, MD, PhD
|
|
|
|
|
|
|
|
|
|
4:30-4:45
|
AKI in Renal and Non-renal Solid Organ Transplantation
|
|
|
|
Vincenzo Cantaluppi, MD
|
|
|
|
|
|
|
|
|
|
4:45-5:00
|
AKI in the Context of Invasive Management of Heart Disease
|
|
|
|
Matthew James, Dr
|
|
|
|
|
|
|
|
|
|
5:00-5:15
|
Arterial and Venous Blood Pressure in Cardiac Surgery Associated AKI
|
|
|
|
Andrew D. Shaw, MB, FRCA, FRCPC
|
|
|
|
|
|
|
|
|
|
5:15-5:30
|
Kidney-Ventilator Interactions and Kidney Protective Ventilation
|
|
|
|
Sean Bagshaw, MD, MSc
|
|
|
|
|
|
|
|
|
|
5:30-5:45
|
ADQI 29: AKI in Liver Cirrhosis
|
|
|
|
Akash Deep, Professor
Mitra Nadim, MD, FASN
|
|
|
|
|
|
|
|
|
|
5:45-6:00
|
ADQI 30: Adsorption-based Extracorporeal Therapies
|
|
|
|
Thiago Reis, MD
Claudio Ronco, MD
|
|
|
|
|
|
|
|
|
|
6:00
|
Adjourn
|
|
|
|
|
|
|
|
|
|
|
|
|
|
6:00-8:00
|
Exhibit Reception and Poster Session
|
|
|
|
Emmanuel Burdmann, MD, PhD
Michael Connor, MD
Lui Forni, MD PhD JFICMI
Kathleen Liu, MD, PhD, MAS
Etienne Macedo, MD, PhD, FASN
Mitchell H. Rosner, MD
|
|
|
|
ORAL POSTER SESSIONS:
CLINICAL RESEARCH IN AKI - II
Forni and Macedo (Moderators)
CLINICAL RESEARCH IN AKI - III
Connor and Liu (Moderators)
EPI AND OUTCOMES - II
Rosner and Burdmann (Moderators)
|
|
|
|
|
|
|
|
|
|
|
|
Thursday, Morning, March 14
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
7:00am-4:30pm
|
Registration Open
|
|
|
|
|
|
|
|
|
|
|
|
|
|
7:00-8:00
|
Coffee Served
|
|
|
|
|
|
|
|
|
|
|
|
|
|
7:00-8:00
|
Meet the Experts
|
|
|
|
|
|
|
|
|
|
|
|
|
7:00-8:00
|
ME3 MEET THE EXPERT
How I Use AKI Biomarkers in My Practice
|
|
|
|
Stuart L. Goldstein, MD
Alex Zarbock, MD
|
|
|
|
|
|
|
|
|
|
7:00-8:00
|
ME4 MEET THE EXPERT
How do I Manage the Oliguric Patient?
|
|
|
|
Ashish Khanna, MD MS FCCP FCCM FASA
Jean-Louis Vincent, MD PhD
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
Morning Symposia
|
|
|
|
|
|
|
|
|
|
|
|
|
7:00-8:00
|
Morning Symposium C. Optimization of the CRRT Program to Improve Outcomes
|
|
|
|
Ian Baldwin, RN, PhD, FACCCN
Manish Kaushik, MD
Oleksa Rewa, MD MSc Slides
David Selewski, MD
Ashita Tolwani, MD
|
|
|
|
CME Available
Ashita Tolwani (Moderator)
Although RRT is commonly applies worldwide there are minimal established criteria for monitoring the quality of care delivered. This symposium will describe the characteristics of top-tier CRRT programs and describe strategies and tools to develop Quality Improvement merging data from CRRT devices and clinical information. The importance of policies, procedures, and dashboards will be discussed.
Establishing Quality Metrics for RRT: Do We Need the EMR? - Kaushik
Team Based Management of CRRT: It Takes a Village - Baldwin
Harnessing Multimodal Data Streams to Improve CRRT Delivery - Rewa Slides
|
|
|
|
|
|
7:00-8:00
|
Morning Symposium D. Onco Nephrology: Practical Considerations in Managing AKI in Patients with Cancer
|
|
|
|
Linda Awdishu, PharmD, MAS
Patrick T. Murray, MD
Marlies Ostermann, PhD
Mitchell H. Rosner, MD
Michael Zappitelli, MD, MSc
|
|
|
|
CME Available
Patrick Murray and Michael Zapitelli (Moderators)
The number of anticancer drugs are increasingly expanding and commonly cause kidney injury. This symposium will discuss how to prevent drug nephrotoxicity, doses of anticancer medicines and manage patients who develop AKI in the setting cancer therapy.
Spectrum of Kidney Disorders with Anticancer Drugs - Mitch Rosner
AKI in Setting of Checkpoint Inhibitors - Marlies Ostermann
Monitoring for Drug Nephrotoxicty - Linda Awdishu
|
|
|
|
|
|
|
|
|
|
8:15-9:45
|
Standard Workshop Group 3
|
|
|
|
|
|
|
|
|
|
|
|
|
8:15-9:45
|
A09 Pediatric AKI and RRT: Beyond the Basics
|
|
|
|
Katie Plomaritas, BSN, RN
Zaccaria Ricci, MD
Michael Zappitelli, MD, MSc
|
|
|
|
This workshop will highlight the epidemiology and best practices for AKI management and CRRT, peritoneal dialysis and tandem therapies application in neonates and children.
|
|
|
|
|
|
8:15-9:45
|
B10 Personalized Fluid Management with CRRT
|
|
|
|
Ravindra L. Mehta, MBBS, MD, DM, FACP
Raghavan Murugan, MD, MS, FRCP
Javier Neyra, MD, MS
|
|
|
|
Achieving fluid balance and maintaining plasma composition is key for effective CRRT. This workshop will use case studies to discuss strategies for fluid management in CRRT to achieve patient driven outcomes for fluid, electrolyte and acid base balance.
|
|
|
|
|
|
8:15-9:45
|
C11 Improving Care for Patients After Hospitalization for AKI
|
|
|
|
Jorge Cerda, MD, MS, FACP, FASN,
Matthew James, Dr
Nuttha Lumlertgul, MD, PhD
|
|
|
|
AKI is a complex disease that requires multidisciplinary interventions however most patients who are hospitalized with an episode of AKI do not have systematic follow up or targeted interventions to improve recovery and mitigate the effects of the disease. This workshop will provide guidance on patient centered approaches to improve the management and outcomes of patients with AKI.
|
|
|
|
|
|
8:15-9:45
|
D12 Managing the Heart Failure Patient with Worsening Renal Function (WRF)
|
|
|
|
Rajasekara Chakravarthi, MD, DNB (Nephrology)
Amir Kazory, MD, FASN, FACC Slides
Claudio Ronco, MD
|
|
|
|
Patients with advanced heart failure often develop WRF. It is often difficult to determine which patients can be managed with drug therapy vs requiring RRT. This workshop will describe the practical application and results of different methods to treat heart failure and cardio-renal syndrome including ultrafiltration techniques.
|
|
|
|
|
|
9:45-10:15
|
Coffee Break
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
SESSION II: CONTROVERSIES IN CRITICAL CARE NEPHROLOGY
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
10:15-10:30
|
Plenary 3 MINI-SYMPOSIA
Challenges in ICU Management
|
|
|
Co-chair: Matthieu LeGrand, MD, PhD
Co-chair: Marlies Ostermann, PhD
|
|
|
|
|
|
|
|
|
|
10:15-10:30
|
From Fluid Responsiveness to Fluid Overload: Identifying Fluid Intolerance
|
|
|
|
William Beaubien-Souligny, Dr
|
|
|
|
|
|
|
|
|
|
10:30-10:45
|
RAAS Biomarkers and Emerging Evidence in Critical Care
|
|
|
|
Ashish Khanna, MD MS FCCP FCCM FASA
|
|
|
|
|
|
|
|
|
|
10:45-11:00
|
Health Disparities in the ICU: What Are the Next Steps?
|
|
|
|
Amira Mohamed, MD
Marlies Ostermann, PhD
|
|
|
|
|
|
|
|
|
|
11:00-11:15
|
Learning Health Systems: Do They Exist and Can They Work?
|
|
|
|
Derek Angus, Dr.
|
|
|
|
|
|
|
|
|
|
11:15-11:30
|
Don't You Forget About Me: Non-ATN Causes of AKI in the ICU
|
|
|
|
Mitchell H. Rosner, MD
|
|
|
|
|
|
|
|
|
|
11:30-11:45
|
Vascular Access for AKI: Tunneled or non-Tunneled?
|
|
|
|
Vandana Niyyar, Dr.
|
|
|
|
|
|
|
|
|
|
11:45-12:15
|
SPECIAL LECTURE
Jeff Gray Memorial Lecture
Translating to Management Award
TBA
|
|
|
|
|
|
|
|
|
|
|
|
|
|
12:15-12:30
|
Top Abstract Awards
|
|
|
|
|
|
|
|
|
|
|
|
|
|
12:30-2:00
|
Lunch Symposia Hosted by Conference (RSVP Required)
Selection made during registration, Non-CME
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Lunch Symposia
|
|
|
|
|
|
|
|
|
|
|
|
|
12:30-2:00
|
Lunch Symposium T1 Social Determinants of Health (SDoH) and AKI
|
|
|
|
Samira Bell, MBChB, FRCP, MD
Rolando Claure-Del Granado, MD, FASN, FISN
Etienne Macedo, MD, PhD, FASN
Mignon McCulloch
Amira Mohamed, MD
|
|
|
|
Despite advances in medical care, racial, ethnic and socioeconomic disparities persist for patients and are increasingly recognized to influence health outcomes. Factors contributing to health disparities are complex and multifactorial and are not well described for patients with AKI. This symposium will discuss the current understanding of the effects of SDoH on the incidence, recognition, management and follow up of patients with AKI and describe approaches for mitigating these factors to improve patient care and outcomes.
Moderators: Mohamed and Claure-Del Granado
Inequalities in Healthcare and Effects on Kidney Disease - Bell
Health disparities in Pediatric AKI - McCullouh
Utilizing Technology to Tackle SDoH - Neyra
|
|
|
|
|
|
12:30-2:00
|
Lunch Symposium T2 Seatbelt for the Kidney: Primary Prevention in Different Settings
|
|
|
|
Patrick T. Murray, MD
Neesh Pannu, MD
Ron Wald, MD
Vincent Wu, MD, PhD
Alex Zarbock, MD
|
|
|
|
Although the kidney is remarkably efficient in maintaining homeostasis, it relies on a delicate balance between energy demand and oxygen supply, which varies considerably in different regions of the kidney. Available data indicate that different AKI-inducing events cause anatomically distinct patterns of injury, which are relevant for the refinement of available therapies and the development of novel renoprotective strategies. This symposium will discuss the rationale for and results of novel strategies to protect the kidney in different settings.
Moderators: Wu and Wald
Drug-induced Kidney Injury - Murray
Contrast Associated Imaging - Pannu
Cardiac Surgery - Zarbock
|
|
|
|
|
|
12:30-2:00
|
I3 Optional Industry Lunch Session (Non-CME)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
12:30-2:00
|
I4 Optional Industry Lunch Session (Non-CME)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
SESSION III: EMERGING CONCEPTS IN AKI AND RRT
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2:00-2:15
|
Plenary 4 MINI SYMPOSIA
Novel Strategies in AKI Management
|
|
|
Co-chair: Patrick T. Murray, MD
Co-chair: Danielle Soranno, MD
|
|
|
|
|
|
|
|
|
|
2:00-2:15
|
Bicarbonate Therapy for AKI. Yes or No?
|
|
|
|
Lui Forni, MD PhD JFICMI
|
|
|
|
|
|
|
|
|
|
2:15-2:30
|
Application for AKI Early Detection and Prediction Models in Clinical Practice
|
|
|
|
SeJoong Kim, Professor
|
|
|
|
|
|
|
|
|
|
2:30-2:45
|
Target Blood Pressure to Prevent AKI: Higher or Normotension?
|
|
|
|
Nattachai Srisawat, MD, PhD
|
|
|
|
|
|
|
|
|
|
2:45-3:00
|
The Aging Kidney: An Old Age Problem
|
|
|
|
Michael Joannidis, Professor, MD
|
|
|
|
|
|
|
|
|
|
3:00-3:15
|
Clinical Decision Support for AKI: Are We There Yet?
|
|
|
|
Neesh Pannu, MD
|
|
|
|
|
|
|
|
|
|
3:15-3:30
|
Urinary Microscopy to Identify Subclinical AKI
|
|
|
|
Rolando Claure-Del Granado, MD, FASN, FISN Slides
|
|
|
|
|
|
|
|
|
|
3:30-3:45
|
Waste Not Want Not: The Case for Acute Dialysis
|
|
|
|
Ravindra L. Mehta, MBBS, MD, DM, FACP
|
|
|
|
|
|
|
|
|
|
3:45-4:15
|
Coffee Break
|
|
|
|
|
|
|
|
|
|
|
|
|
|
4:15-4:30
|
Plenary 5 MINI SYMPOSIA
Challenges and Controversies in Renal Support and CRRT
|
|
|
Co-chair: Michael Connor, MD
Co-chair: Katja Gist, DO, MSc
|
|
|
|
|
|
|
|
|
|
4:15-4:30
|
To dialyze or Not: That is the Question?
|
|
|
|
Mitra Nadim, MD, FASN
|
|
|
|
|
|
|
|
|
|
4:30-4:45
|
Dynamic Phenotyping for Dialysis Delivery in the ICU
|
|
|
|
Ravindra L. Mehta, MBBS, MD, DM, FACP
|
|
|
|
|
|
|
|
|
|
4:45-5:00
|
Leveraging Personal Health Platforms for AKI Followup
|
|
|
|
Rajit Basu, MD MS FCCM
|
|
|
|
|
|
|
|
|
|
5:00-5:15
|
Dialysis in AKI: When is a Good Thing Bad?
|
|
|
|
Kathleen Liu, MD, PhD, MAS
|
|
|
|
|
|
|
|
|
|
5:15-5:30
|
Albumin and Clinical Outcomes in AKI and CRRT
|
|
|
|
Kianoush Kashani, MD, MS
|
|
|
|
|
|
|
|
|
|
5:30-5:45
|
ADQI 31: Endpoints for AKI Trials
|
|
|
|
Lui Forni, MD PhD JFICMI
Alex Zarbock, MD
|
|
|
|
|
|
|
|
|
|
5:45-6:00
|
ADQI 32: Role of Sex and Gender in AKI (SexXY ADQI)
|
|
|
|
Marlies Ostermann, PhD
Danielle Soranno, MD
|
|
|
|
|
|
|
|
|
|
6:00
|
Adjourn
Free Evening
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Friday Morning, March 15
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
7:00am-1:00pm
|
Conference Registration Open
|
|
|
|
|
|
|
|
|
|
|
|
|
|
7:30-8:00
|
Coffee Served
|
|
|
|
|
|
|
|
|
|
|
|
|
|
7:00-8:00
|
Meet the Experts
|
|
|
|
|
|
|
|
|
|
|
|
|
7:00-8:00
|
ME5 MEET THE EXPERT
Deciding who Needs to Start and Stop RRT
|
|
|
|
Marlies Ostermann, PhD
Ron Wald, MD
|
|
|
|
|
|
|
|
|
|
7:00-8:00
|
ME6 MEET THE EXPERT
How do I Assess the Volume Status of My Patient?
|
|
|
|
Kianoush Kashani, MD, MS
Peter Pickkers, MD, PhD
|
|
|
|
|
|
|
|
|
|
7:00-8:00
|
Morning Symposia
|
|
|
|
|
|
|
|
|
|
|
|
|
7:00-8:00
|
Morning Symposium E - Innovations in Caring for Patients with Electrolyte and Acid Base Problems
|
|
|
|
Nuttha Lumlertgul, MD, PhD
Lenar Yessayan, MD, MS Slides
|
|
|
|
Etienne Macedo (Moderator)
Yessayan and Lumertgul (Discussants) Slides
Dysnatremias are commonly encountered in ICU patients and are often difficult to manage. This symposium will cover the pathophysiology of hypo and hypernatremia and discuss the practical issues for management of these disorders with novel agents and describe how RRT can be used for severe disorders.
|
|
|
|
|
|
7:00-8:00
|
Morning Symposium F - Optimizing Fluid Management in the ICU: Fit for Purpose?
|
|
|
|
Michael Connor, MD
Ashish Khanna, MD MS FCCP FCCM FASA
Andrew D. Shaw, MB, FRCA, FRCPC
|
|
|
|
Connor (Moderator)
Shaw and Khanna (Discussants)
Fluid administration is an integral component of management, however there is considerable variation in the type and quantity of fluids used and increasing concern that fluid therapy contributes to AKI. This symposium will review the evidence for our current strategy for using crystalloids, colloids and blood products and provide guidance on best practices to manage patients in different settings.
|
|
|
|
|
|
|
|
|
|
|
|
SESSION IV: IMPROVING OUTCOMES IN AKI
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
8:00-8:15
|
Plenary 6 MINI SYMPOSIA
Global Burden of AKI
|
|
|
Co-chair: Etienne Macedo, MD, PhD, FASN
Co-chair: Nattachai Srisawat, MD, PhD
|
|
|
|
|
|
|
|
|
|
8:00-8:15
|
Personalization and Standardization of RRT in the ICU: Lessons from Pediatrics
|
|
|
|
David Askenazi, MD, MSPH
|
|
|
|
|
|
|
|
|
|
8:15-8:30
|
Education in AKI: What's Needed?
|
|
|
|
Jorge Cerda, MD, MS, FACP, FASN,
|
|
|
|
|
|
|
|
|
|
8:30-8:45
|
Long-COVID Manifesting as Kidney Disease
|
|
|
|
Emmanuel Burdmann, MD, PhD
|
|
|
|
|
|
|
|
|
|
8:45-9:00
|
Quality of Life Post AKI
|
|
|
|
Marlies Ostermann, PhD
|
|
|
|
|
|
|
|
|
|
9:00-9:15
|
Nephrology Consultation in the ICU: Who Benefits?
|
|
|
|
Harin Rhee, MD., PhD.
|
|
|
|
|
|
|
|
|
|
9:15-9:30
|
What Outcomes Matter to Patients and Their Relatives?
|
|
|
|
Sean Bagshaw, MD, MSc
|
|
|
|
|
|
|
|
|
|
9:30-9:45
|
Does Treating AKI in Low Resourced Regions Matter?
|
|
|
|
Mignon McCulloch
|
|
|
|
|
|
|
|
|
|
9:45-10:00
|
Variation in Pediatric CKRT Practices Across the Globe
|
|
|
|
Akash Deep, Professor
|
|
|
|
|
|
|
|
|
|
10:00-10:15
|
CRRT Net Initiative: Lessons Learned and Applied
|
|
|
|
Javier Neyra, MD, MS
|
|
|
|
|
|
|
|
|
|
10:15-10:30
|
ADQI 33: Obstetric AKI
|
|
|
|
Rajasekara Chakravarthi, MD, DNB (Nephrology)
|
|
|
|
|
|
|
|
|
|
10:30-11:00
|
Coffee Break
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
SESSION V: FUTURE TRENDS IN CRRT AND CRITICAL CARE
|
|
|
|
|
|
|
|
|
|
|
|
|
|
11:00-11:15
|
Plenary 7 MINI SYMPOSIA
Emerging Strategies in AKI and Extracorporeal Support
|
|
|
Co-chair: Jorge Cerda, MD, MS, FACP, FASN,
Co-chair: Vincent Wu, MD, PhD
|
|
|
|
|
|
|
|
|
|
11:00-11:15
|
Transitions from CRRT to IRRT: Strategies for Success
|
|
|
|
Ron Wald, MD
|
|
|
|
|
|
|
|
|
|
11:15-11:30
|
Reassessing AKD Care and Outcomes: Time to Abandon Conventional Beliefs
|
|
|
|
Vincent Wu, MD, PhD
|
|
|
|
|
|
|
|
|
|
11:30-12:30
|
Update from Ongoing and Late Breaking Trials
(8-10 minutes each)
|
|
|
|
Vincenzo Cantaluppi, MD
Katja Gist, DO, MSc
Jay Koyner, MD
Raghavan Murugan, MD, MS, FRCP
Javier Neyra, MD, MS
Christian Nusshag, MD
Vedran Premuzic, M.D., Ph.D.
Oleksa Rewa, MD MSc
|
|
|
|
1. The RELIEVE-AKI Trial - Murugan
2. The RECOVER AKI Trial - Neyra
3. Dialyzing Wisely Trial - Rewa
4. The HERRIC Registry - Premuzic
5. The RELAX Trial - Nusshag
6. WE-ROCK, the Pediatric RRT Collaborative - Gist
7. The DIAMOND Study - Koyner
8. The SIN-AKI Study - Cantaluppi
|
|
|
|
|
|
12:30-12:55
|
Critical Care Nephrology: Literature Review
|
|
|
|
Kianoush Kashani, MD, MS
|
|
|
|
|
|
|
|
|
|
12:55-1:00
|
Closing Remarks
|
|
|
|
Ravindra L. Mehta, MBBS, MD, DM, FACP
|
|
|
|
|
|
|
|
|
|
1:00
|
Conference Adjourns
|
|
|
|
|
|
|
|
|
